<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02135250</url>
  </required_header>
  <id_info>
    <org_study_id>2013022</org_study_id>
    <nct_id>NCT02135250</nct_id>
  </id_info>
  <brief_title>Study on Therapeutic Effect of Treating Mental Stress Induced Myocardial Ischemia</brief_title>
  <official_title>Study on Therapeutic Effect of Treating Mental Stress Induced Myocardial Ischemia With Conventional Therapy for Coronary Heart Disease Combined With Traditional Chinese Medicine :Design and Methods</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Meiyan Liu</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beijing Anzhen Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to discuss whether the combined treatment of traditional Chinese medicine
      (TCM) and western medicine for Mental Stress Induced Myocardial Ischemia (MSIMI) does effect,
      namely the conventional therapy for Coronary Heart Disease( CHD) combining with TCM -
      Xinkeshu tablets.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A large number of evidence-based medical researches have proven that bad mood and mental
      stress are related to poor prognosis. Having recognized that acute emotional stress can
      induce cardiovascular events, many clinical tests of mental stress have been carried out to
      observe the correlation between emotional stress and cardiac damage, which ultimately lead to
      the formalization of the concept of Mental Stress Induced Myocardial Ischemia(MSIMI). In the
      past 3 decades, it has been evidenced that mental stress is internally related to myocardial
      ischemia. According to current studies, over 70% patients with stable coronary heart disease
      have MSIMI and are exposed to three or four times higher risk of cardiovascular events.
      However, few articles are about the therapeutic effect of MSIMI treatment. This study aims to
      discuss whether the combined treatment of traditional Chinese medicine (TCM) and western
      medicine for MSIMI does effect, namely the conventional therapy for CHD combining with TCM -
      Xinkeshu tablets.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">July 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Left ventricular ejection fraction</measure>
    <time_frame>up to 8 weeks</time_frame>
    <description>reduction of LVEF by 5% or more</description>
  </primary_outcome>
  <primary_outcome>
    <measure>ventricular wall motion</measure>
    <time_frame>up to 8 weeks</time_frame>
    <description>Echocardiography to assess the ventricular wall motion in one cardiac cycle starting from the systole</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Theraphy of Chinese Traditional Medicine</condition>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>the placebo is not drug</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Xinkeshu tablet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>4 Xinkeshu tablets are given three times per day</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Xinkeshu tablets</intervention_name>
    <description>4 Xinkeshu tablets are given three times per day</description>
    <arm_group_label>Xinkeshu tablet</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>the placebo is not drug.</description>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. above 18 years old,

          2. having coronary stenosis (&gt; 70%) measured by coronary arteriography,

          3. with medical history of myocardial infarction or revascularization procedures,

          4. or with sufficient proof for having CHD.

        Exclusion Criteria:

          1. patient age younger than 18,

          2. clearly impaired cognitive function,

          3. damage of functions of vital organs,

          4. suicidal ideation,

          5. mental diseases treated with selective serotonin reuptake inhibitor (SSRI)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anzhen Beijing</last_name>
    <role>Principal Investigator</role>
    <affiliation>Capital Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Liu Meiyan</last_name>
    <phone>13001241364</phone>
    <phone_ext>86</phone_ext>
    <email>zhanglijun0411@126.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Beijing Anzhen Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100029</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Liu Meiyan</last_name>
      <phone>13001241364</phone>
      <phone_ext>86</phone_ext>
      <email>zhanglijun0411@126.com</email>
    </contact>
    <investigator>
      <last_name>Liu Meiyan</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Faxon DP, Creager MA, Smith SC Jr, Pasternak RC, Olin JW, Bettmann MA, Criqui MH, Milani RV, Loscalzo J, Kaufman JA, Jones DW, Pearce WH; American Heart Association. Atherosclerotic Vascular Disease Conference: Executive summary: Atherosclerotic Vascular Disease Conference proceeding for healthcare professionals from a special writing group of the American Heart Association. Circulation. 2004 Jun 1;109(21):2595-604.</citation>
    <PMID>15173041</PMID>
  </reference>
  <reference>
    <citation>Strike PC, Steptoe A. Systematic review of mental stress-induced myocardial ischaemia. Eur Heart J. 2003 Apr;24(8):690-703. Review.</citation>
    <PMID>12713764</PMID>
  </reference>
  <reference>
    <citation>Jiang W, Babyak M, Krantz DS, Waugh RA, Coleman RE, Hanson MM, Frid DJ, McNulty S, Morris JJ, O'Connor CM, Blumenthal JA. Mental stress--induced myocardial ischemia and cardiac events. JAMA. 1996 Jun 5;275(21):1651-6.</citation>
    <PMID>8637138</PMID>
  </reference>
  <reference>
    <citation>Sheps DS, McMahon RP, Becker L, Carney RM, Freedland KE, Cohen JD, Sheffield D, Goldberg AD, Ketterer MW, Pepine CJ, Raczynski JM, Light K, Krantz DS, Stone PH, Knatterud GL, Kaufmann PG. Mental stress-induced ischemia and all-cause mortality in patients with coronary artery disease: Results from the Psychophysiological Investigations of Myocardial Ischemia study. Circulation. 2002 Apr 16;105(15):1780-4.</citation>
    <PMID>11956119</PMID>
  </reference>
  <reference>
    <citation>Liu Y, Huang Y, Zhao C, Qin X, Zhu Q, Chen S, Qu J. Salvia miltiorrhiza injection on pulmonary heart disease: a systematic review and meta-analysis. Am J Chin Med. 2014;42(6):1315-31. doi: 10.1142/S0192415X14500827.</citation>
    <PMID>25395310</PMID>
  </reference>
  <reference>
    <citation>Zhong LY, Shen ZY, Cai DF. [Effect of three kinds (tonifying kidney, invigorating spleen, promoting blood circulation) recipes on the hypothalamus-pituitary-adrenal-thymus (HPAT) axis and CRF gene expression]. Zhongguo Zhong Xi Yi Jie He Za Zhi. 1997 Jan;17(1):39-41. Chinese.</citation>
    <PMID>9812651</PMID>
  </reference>
  <reference>
    <citation>Gao Y, Zhang K, Zhu F, Wu Z, Chu X, Zhang X, Zhang Y, Zhang J, Chu L. Salvia miltiorrhiza (Danshen) inhibits L-type calcium current and attenuates calcium transient and contractility in rat ventricular myocytes. J Ethnopharmacol. 2014 Dec 2;158 Pt A:397-403. doi: 10.1016/j.jep.2014.10.049. Epub 2014 Oct 31.</citation>
    <PMID>25446591</PMID>
  </reference>
  <reference>
    <citation>Maji AK, Pandit S, Banerji P, Banerjee D. Pueraria tuberosa: a review on its phytochemical and therapeutic potential. Nat Prod Res. 2014;28(23):2111-27. doi: 10.1080/14786419.2014.928291. Epub 2014 Jul 1. Review.</citation>
    <PMID>24980468</PMID>
  </reference>
  <reference>
    <citation>Zhao S, Zheng MX, Chen HE, Wu CY, Wang WT. Effect of panax notoginseng saponins injection on the p38MAPK pathway in lung tissue in a rat model of hypoxic pulmonary hypertension. Chin J Integr Med. 2015 Feb;21(2):147-51. doi: 10.1007/s11655-014-1790-2. Epub 2014 Dec 19.</citation>
    <PMID>25523598</PMID>
  </reference>
  <reference>
    <citation>Huang SS, Deng JS, Lin JG, Lee CY, Huang GJ. Anti-inflammatory effects of trilinolein from Panax notoginseng through the suppression of NF-κB and MAPK expression and proinflammatory cytokine expression. Am J Chin Med. 2014;42(6):1485-506. doi: 10.1142/S0192415X14500931.</citation>
    <PMID>25482678</PMID>
  </reference>
  <reference>
    <citation>Ghanbari-Niaki A, Ghanbari-Abarghooi S, Rahbarizadeh F, Zare-Kookandeh N, Gholizadeh M, Roudbari F, Zare-Kookandeh A. Heart ABCA1 and PPAR- α Genes Expression Responses in Male rats: Effects of High Intensity Treadmill Running Training and Aqueous Extraction of Black Crataegus-Pentaegyna. Res Cardiovasc Med. 2013 Nov;2(4):153-9. doi: 10.5812/cardiovascmed.13892. Epub 2013 Oct 28.</citation>
    <PMID>25478513</PMID>
  </reference>
  <reference>
    <citation>Coulter SA, Campos K. Identify and treat depression for reduced cardiac risk and improved outcomes. Tex Heart Inst J. 2012;39(2):231-4.</citation>
    <PMID>22740739</PMID>
  </reference>
  <reference>
    <citation>Goldberg AD, Becker LC, Bonsall R, Cohen JD, Ketterer MW, Kaufman PG, Krantz DS, Light KC, McMahon RP, Noreuil T, Pepine CJ, Raczynski J, Stone PH, Strother D, Taylor H, Sheps DS. Ischemic, hemodynamic, and neurohormonal responses to mental and exercise stress. Experience from the Psychophysiological Investigations of Myocardial Ischemia Study (PIMI). Circulation. 1996 Nov 15;94(10):2402-9.</citation>
    <PMID>8921780</PMID>
  </reference>
  <reference>
    <citation>Jain D, Shaker SM, Burg M, Wackers FJ, Soufer R, Zaret BL. Effects of mental stress on left ventricular and peripheral vascular performance in patients with coronary artery disease. J Am Coll Cardiol. 1998 May;31(6):1314-22.</citation>
    <PMID>9581726</PMID>
  </reference>
  <reference>
    <citation>Kop WJ, Krantz DS, Howell RH, Ferguson MA, Papademetriou V, Lu D, Popma JJ, Quigley JF, Vernalis M, Gottdiener JS. Effects of mental stress on coronary epicardial vasomotion and flow velocity in coronary artery disease: relationship with hemodynamic stress responses. J Am Coll Cardiol. 2001 Apr;37(5):1359-66.</citation>
    <PMID>11300447</PMID>
  </reference>
  <reference>
    <citation>Schöder H, Silverman DH, Campisi R, Sayre JW, Phelps ME, Schelbert HR, Czernin J. Regulation of myocardial blood flow response to mental stress in healthy individuals. Am J Physiol Heart Circ Physiol. 2000 Feb;278(2):H360-6.</citation>
    <PMID>10666065</PMID>
  </reference>
  <reference>
    <citation>Schöder H, Silverman DH, Campisi R, Karpman H, Phelps ME, Schelbert HR, Czernin J. Effect of mental stress on myocardial blood flow and vasomotion in patients with coronary artery disease. J Nucl Med. 2000 Jan;41(1):11-6.</citation>
    <PMID>10647599</PMID>
  </reference>
  <reference>
    <citation>Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA. 1995 Oct 4;274(13):1049-57.</citation>
    <PMID>7563456</PMID>
  </reference>
  <reference>
    <citation>Woo KS, Sanderson JE, Sun YY, Chook P, Cheung AS, Chan LT, Metreweli C, Lolin YI, Celermajer DS. Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans. Circulation. 2000 Mar 28;101(12):E116.</citation>
    <PMID>10736298</PMID>
  </reference>
  <reference>
    <citation>Laaksonen R, Janatuinen T, Vesalainen R, Lehtimäki T, Elovaara I, Jaakkola O, Jokela H, Laakso J, Nuutila P, Punnonen K, Raitakari O, Saikku P, Salminen K, Knuuti J. High oxidized LDL and elevated plasma homocysteine contribute to the early reduction of myocardial flow reserve in healthy adults. Eur J Clin Invest. 2002 Nov;32(11):795-802.</citation>
    <PMID>12423319</PMID>
  </reference>
  <reference>
    <citation>Morrow DA, Cannon CP, Jesse RL, Newby LK, Ravkilde J, Storrow AB, Wu AH, Christenson RH; National Academy of Clinical Biochemistry. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Circulation. 2007 Apr 3;115(13):e356-75. Epub 2007 Mar 23.</citation>
    <PMID>17384331</PMID>
  </reference>
  <reference>
    <citation>de Lemos JA, Drazner MH, Omland T, Ayers CR, Khera A, Rohatgi A, Hashim I, Berry JD, Das SR, Morrow DA, McGuire DK. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA. 2010 Dec 8;304(22):2503-12. doi: 10.1001/jama.2010.1768. Erratum in: JAMA. 2011 Mar 23;305(12):1200.</citation>
    <PMID>21139111</PMID>
  </reference>
  <reference>
    <citation>Bass A, Patterson JH, Adams KF Jr. Perspective on the clinical application of troponin in heart failure and states of cardiac injury. Heart Fail Rev. 2010 Jul;15(4):305-17. doi: 10.1007/s10741-008-9124-8. Epub 2009 Apr 5. Review.</citation>
    <PMID>19347578</PMID>
  </reference>
  <verification_date>January 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 6, 2014</study_first_submitted>
  <study_first_submitted_qc>May 8, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 9, 2014</study_first_posted>
  <last_update_submitted>January 26, 2015</last_update_submitted>
  <last_update_submitted_qc>January 26, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 27, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Beijing Anzhen Hospital</investigator_affiliation>
    <investigator_full_name>Meiyan Liu</investigator_full_name>
    <investigator_title>physician</investigator_title>
  </responsible_party>
  <keyword>Traditional Chinese Medicine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Stress, Psychological</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

